Positron Emission Tomography/Magnetic Resonance Imaging of Gastrointestinal Cancers.

As an integrated system, hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) is able to provide simultaneously complementary high-resolution anatomic, molecular, and functional information, allowing comprehensive cancer phenotyping in a single imaging examination. In addition to an improved patient experience by combining 2 separate imaging examinations and streamlining the patient pathway, the superior soft tissue contrast resolution of MRI and the ability to acquire multiparametric MRI data is advantageous over computed tomography. For gastrointestinal cancers, this would improve tumor staging, assessment of neoadjuvant response, and of the likelihood of a complete (R0) resection in comparison with positron emission tomography or computed tomography.

[1]  J. Lee,et al.  Added Value of Integrated Whole-Body PET/MRI for Evaluation of Colorectal Cancer: Comparison With Contrast-Enhanced MDCT. , 2016, AJR. American journal of roentgenology.

[2]  J. Thompson,et al.  The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation , 2007, European Radiology.

[3]  Markus Schwaiger,et al.  Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology , 2012, The Journal of Nuclear Medicine.

[4]  H. Zaidi,et al.  Design and performance evaluation of a whole-body Ingenuity TF PET–MRI system , 2011, Physics in medicine and biology.

[5]  Paul K Marsden,et al.  PET-MRI: a review of challenges and solutions in the development of integrated multimodality imaging , 2015, Physics in medicine and biology.

[6]  Jae Sung Lee,et al.  Comparison of Segmentation-Based Attenuation Correction Methods for PET/MRI: Evaluation of Bone and Liver Standardized Uptake Value with Oncologic PET/CT Data , 2012, The Journal of Nuclear Medicine.

[7]  J. Nuyts,et al.  Completion of a Truncated Attenuation Image From the Attenuated PET Emission Data , 2010, IEEE Transactions on Medical Imaging.

[8]  M. Forsting,et al.  Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. , 2013, European journal of radiology.

[9]  Peter Faulhaber,et al.  Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in an Oncology Patient Population , 2013, Molecular Imaging and Biology.

[10]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[11]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[12]  Brian M Dale,et al.  Abdominal MRI at 3.0 T: the basics revisited. , 2006, AJR. American journal of roentgenology.

[13]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  B. Schölkopf,et al.  Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  K. Herrmann,et al.  Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study , 2015, Abdominal Imaging.

[16]  Kyoungjune Pak,et al.  Clinical Implication of PET/MR Imaging in Preoperative Esophageal Cancer Staging: Comparison with PET/CT, Endoscopic Ultrasonography, and CT , 2014, The Journal of Nuclear Medicine.

[17]  P. Heusch,et al.  Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases , 2015, PloS one.

[18]  Paul Dufort,et al.  Multiparameteric PET-MR Assessment of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: PET, MR, PET-MR and Tumor Texture Analysis: A Pilot Study , 2015 .

[19]  P. D. Peppercorn,et al.  Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study , 2006, BMJ : British Medical Journal.

[20]  N. Schwenzer,et al.  Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  S. Vandenberghe,et al.  MRI-Based Attenuation Correction for PET/MRI Using Ultrashort Echo Time Sequences , 2010, Journal of Nuclear Medicine.

[22]  Thomas Beyer,et al.  X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. , 2003, Seminars in nuclear medicine.

[23]  Felix Nensa,et al.  Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI. , 2013, European journal of radiology.

[24]  A. Riddell,et al.  High-resolution MRI in evaluation of the surgical anatomy of the esophagus and posterior mediastinum. , 2007, AJR. American journal of roentgenology.

[25]  A. Kessels,et al.  Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery , 2001, The Lancet.

[26]  Gudrun Wagenknecht,et al.  MRI for attenuation correction in PET: methods and challenges , 2012, Magnetic Resonance Materials in Physics, Biology and Medicine.

[27]  Devin W. Steenkamp,et al.  Metformin may be associated with false-negative cancer detection in the gastrointestinal tract on PET/CT. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.